NuVasive | Eigenkapital Und Reserven



Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Cooper Companies USD 8.35B 64.9M 2025-06
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Globus Medical USD 4.4B 103.14M 2025-09
Haemonetics USD 911.45M 62.28M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 1.09M 2025-09
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 78.47B 0 2025-09
Medtronic USD 48.86B 964M 2025-09
Merit Medical Systems USD 1.53B 41.36M 2025-09
Orthofix International USD 442.49M 15.86M 2025-09
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.82B 421M 2025-09
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12


NuVasive Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.